Volume | 0 |
|
|||||
Actualités | - | ||||||
Maximum Haut | Bas Haut |
||||||
Minimum Bas |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Eiger BioPharmaceuticals Inc | EIGR | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
1,725 |
Transactions Totales | Volume échangé | Volume en moyenne | Sur 52 semaines |
---|---|---|---|
0 | 0 | - | 1,10 - 43,35 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
- | 0 | US$ 1,725 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
US$ 2,55M | - | - | - | -2,64 |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action Eiger BioPharmaceuticals
Date | Heure | Source | Titre |
---|---|---|---|
01/4/2024 | 17:12 | GlobeNewswire Inc. | Eiger BioPharmaceuticals Files for Voluntary Chapter 11.. |
11/3/2024 | 21:03 | Edgar (US Regulatory) | Form 8-K - Current report |
24/1/2024 | 22:59 | Edgar (US Regulatory) | Form 8-K - Current report |
18/1/2024 | 23:49 | PR Newswire (US) | Eiger and Partner, AnGes, Receive Approval for Zokinvy®.. |
08/1/2024 | 13:00 | Edgar (US Regulatory) | Form 8-K - Current report |
04/1/2024 | 14:45 | Edgar (US Regulatory) | Form 8-K - Current report |
04/1/2024 | 14:00 | PR Newswire (US) | Eiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse.. |
11/12/2023 | 22:01 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
04/12/2023 | 12:01 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of.. |
01/12/2023 | 22:02 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
24/11/2023 | 12:01 | Edgar (US Regulatory) | Form SC 13D - General statement of acquisition of beneficial.. |
13/11/2023 | 22:01 | Edgar (US Regulatory) | Form 8-K - Current report |
Forum Action Eiger BioPharmaceuticals
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Eiger BioPharmaceuticals Inc
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
1 mois | 2,40 | 2,5977 | 1,66 | 2,08 | 173 571 | -0,675 | -28,13% |
3 mois | 6,09 | 8,2672 | 1,10 | 2,03 | 165 371 | -4,37 | -71,67% |
6 mois | 10,20 | 14,337 | 1,10 | 5,92 | 181 597 | -8,48 | -83,09% |
1 an | 33,00 | 43,35 | 1,10 | 16,31 | 300 814 | -31,28 | -94,77% |
3 ans | 256,80 | 300,639 | 1,10 | 121,97 | 426 852 | -255,08 | -99,33% |
5 ans | 322,80 | 474,60 | 1,10 | 185,12 | 381 302 | -321,08 | -99,47% |